Fig. 7.

Combination therapy with miR-532-5p and orlistat has synergistic effects in vivo. (A) Representative images of dissected tumors. (B) Subcutaneous tumor growth curves of mice and the average weight of tumors in different treatment groups are depicted. (C) The enrichment of fat vacuoles. (D) Representative images of HE staining of lymph nodes from nude mice. (E) The LNM rate. (F) Mean tumor volume over time (n = 10). (G) KM analyses of OS and DFS in CC patients based on the risk score of miR-532-5p and FASN. *, P < 0.05; **, P < 0.01; ***, P < 0.001.